RxDoctor Payments Data

Michael Yu, MD

Gastroenterology · Atlanta, GANPI 1487185245

Payments from drug & device makers

What this record shows

This record is dominated by grants: $16,547 of the $23,216 with a category attached, or 71.3%. Cook Incorporated accounts for 71.3% of it on its own, with 4 other manufacturers making up the rest. Reporting peaked in 2024 at $12,958 and has fallen 95.9% since, to $536 in 2025. Among gastroenterology clinicians in GA with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$23,216in general payments, 2019–2025

Across 41 payments — averaging $566.25 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Cook Incorporated$17K
  • Boston Scientific$6K
  • Fujifilm Healthcare Americas Corporation$634
  • Medtronic$281
  • AbbVie$96

What the payments were for

  • Grants$16,54771%
  • Travel & lodging$3,55615%
  • Food & beverage$3,11413%

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$23,216 in reported general payments places this provider in the 90th percentile of 492 gastroenterology providers in Georgia.

See all gastroenterology providers in Georgia

Medicare billing

Part B allowed, 2024
$7,157
Medicare patients
49
Services billed
63

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Sucralfate14$904
Omeprazole13$500
Pantoprazole Sodium11$174
Ciprofloxacin Hcl11$29

Paid to pharmacies, not to this prescriber.

Other gastroenterology in Atlanta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →